James Hambro & Partners
JNJ icon

James Hambro & Partners’s Johnson & Johnson JNJ Stock Holding History

James Hambro & Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$671K Buy
2,534
+859
+51% +$227K 0.02% 46
2026
Q2 		$425K Sell
1,675
-34
-2% -$7.92K 0.02% 55
2026
Q1 		$418K Buy
1,709
+243
+17% +$56.6K 0.02% 44
2025
Q4 		$303K Sell
1,466
-852
-37% -$168K 0.01% 47
2025
Q3 		$430K Sell
2,318
-140
-6% -$24K 0.02% 44
2025
Q2 		$375K Sell
2,458
-380
-13% -$58.4K 0.01% 42
2025
Q1 		$471K Hold
2,838
– – 0.02% 44
2024
Q4 		$410K Sell
2,838
-800
-22% -$124K 0.02% 47
2024
Q3 		$589K Sell
3,638
-140
-4% -$22.3K 0.02% 42
2024
Q2 		$552K Sell
3,778
-316
-8% -$47K 0.03% 40
2024
Q1 		$648K Buy
4,094
+472
+13% +$75.1K 0.03% 37
2023
Q4 		$568K Sell
3,622
-566
-14% -$86.8K 0.03% 37
2023
Q3 		$652K Buy
4,188
+51
+1% +$8.42K 0.04% 37
2023
Q2 		$684K Buy
4,137
+300
+8% +$48.4K 0.05% 38
2023
Q1 		$594K Buy
3,837
+441
+13% +$71.2K 0.04% 42
2022
Q4 		$600K Hold
3,396
– – 0.05% 40
2022
Q3 		$555K Hold
3,396
– – 0.05% 41
2022
Q2 		$604K Sell
3,396
-210
-6% -$37.4K 0.05% 40
2022
Q1 		$640K Sell
3,606
-155
-4% -$26.4K 0.05% 40
2021
Q4 		$644K Hold
3,761
– – 0.04% 42
2021
Q3 		$607K Buy
3,761
+155
+4% +$26.4K 0.05% 47
2021
Q2 		$594K Sell
3,606
-4,749
-57% -$786K 0.05% 42
2021
Q1 		$1.37M Buy
8,355
+4,751
+132% +$769K 0.13% 29
2020
Q4 		$567K Sell
3,604
-12
-0.3% -$1.77K 0.06% 39
2020
Q3 		$537K Sell
3,616
-2,600
-42% -$385K 0.08% 36
2020
Q2 		$873K Buy
6,216
+3,400
+121% +$495K 0.14% 32
2020
Q1 		$369K Hold
2,816
– – 0.07% 39
2019
Q4 		$411K Hold
2,816
– – 0.07% 41
2019
Q3 		$364K Buy
+2,816
New +$371K 0.07% 39
2019
Q1 		$442K Sell
3,161
-50
-2% -$6.7K 0.13% 35
2018
Q4 		$414K Buy
+3,211
New +$448K 0.16% 35

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

James Hambro & Partners's JNJ Position: Q3 2026 in Review

James Hambro & Partners increased its Johnson & Johnson (JNJ) stake by 51% in Q3 2026, buying an estimated $227K and bringing the position to 2,534 shares worth $671K. The position accounts for 0.02% of the portfolio, ranked #46.

James Hambro & Partners first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.37M in Q1 2021. 2,215 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • James Hambro & Partners held 2,534 shares of Johnson & Johnson worth $671K as of Q3 2026.
  • James Hambro & Partners bought 859 Johnson & Johnson shares in Q3 2026, an estimated $227K.
  • Johnson & Johnson made up 0.02% of James Hambro & Partners's portfolio in Q3 2026, its #46 holding.
  • James Hambro & Partners first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
  • James Hambro & Partners's Johnson & Johnson position peaked at $1.37M in Q1 2021.
  • 2,215 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on James Hambro & Partners's 13F filing for Q3 2026, filed 19 Oct 2026.